Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
about
Hepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer ChallengeA phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors.Antivascular therapy for epithelial ovarian cancer.Phenotype and genotype of pancreatic cancer cell linesSimultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancerNicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotypePhase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.The SRC family of protein tyrosine kinases: a new and promising target for colorectal cancer therapy.1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors.Biological agents versus chemotherapy in the treatment of colorectal cancer.MDA-9/syntenin and IGFBP-2 promote angiogenesis in human melanomaNicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer MicroenvironmentSynergistic activity of the SRC family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stressNew treatment options for advanced pancreatic cancer.Selective disruption of rb-raf-1 kinase interaction inhibits pancreatic adenocarcinoma growth irrespective of gemcitabine sensitivity.Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.Emerging drugs in the treatment of pancreatic cancer.Molecular changes in pancreatic cancer.Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.Could signal transducer and activator of transcription 3 be a therapeutic target in obesity-related gastrointestinal malignancy?Src signaling pathways in prostate cancer.Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity.Aflatoxin B1 induces Src phosphorylation and stimulates lung cancer cell migration.Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells.Stress hormones regulate interleukin-6 expression by human ovarian carcinoma cells through a Src-dependent mechanism.Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.Targeting SRC and epidermal growth factor receptor in colorectal cancer: rationale and progress into the clinic.Autophagy Blockade Sensitizes Prostate Cancer Cells towards Src Family Kinase Inhibitors.Primary outgrowth cultures are a reliable source of human pancreatic stellate cells.
P2860
Q26781273-EC1489AE-B12E-42C1-8CA6-3DEB04AF4CF3Q33404541-F842120C-5C06-49DC-A855-DAFABF73E5BEQ33583598-EE1BE1D2-7E21-41DD-93E2-258AADAF50B8Q33814471-588ACF43-A35D-4FC8-84F0-4270EF7BFE1CQ33889288-F6E1A749-213D-4F16-AB57-960CC3092A4DQ34091347-46A1002A-CC64-41CB-8BFF-B22DC15680EAQ34322085-35DCE938-EFCF-4108-BCE7-C3D69BBE2856Q34490721-97E02060-2233-4750-BD38-875B5D2FB64CQ34578584-AADE8431-293E-469F-B65E-38A541367EB9Q34966503-F1CB5A6E-6F4B-4CD5-9B9C-C199582B11A8Q35020469-6890C83D-E647-42C8-972A-70D99340F7ADQ35076957-2691578B-A5EF-4D12-A655-73C7C40546E2Q35088031-D36A1CC1-8F26-4F1A-AD38-31CFD0EBFE1FQ35205410-931AE76A-B104-4C02-BD10-B03D550E15DCQ35456086-5DEA1E63-4878-4CAB-A5A4-9443853CAE3AQ35456945-9594BDBF-8303-43DB-8F4B-F100600D3E83Q36521850-39DF2CA1-81FE-4811-8BF5-605AB3C82662Q36545071-58E39E21-A4BB-4FCA-A84B-F1B39D7419E7Q36759077-C5D1047E-C5BD-436E-93F9-44F11F0D6654Q37259527-FC55E426-56F7-44FE-9E3E-192E8C4ED8BDQ37345841-67189B7F-6FA2-4D44-A2D4-391C58EBF15CQ37381557-1EC61B27-A2A7-40E8-AF11-94E88822C66FQ37455222-EF1E9C14-347D-4B65-B397-9B71BE3D0B83Q37494647-A4D38A8F-972F-4DBB-A0AE-1E1A78D1AF84Q37614592-0F53CD61-3D34-494A-80B9-47A66C6CD6CCQ37702064-E316A718-12B7-4876-B63C-2D33C33343E0Q38155819-BE27D03A-DF38-4328-AFF2-90304C6701A4Q38187565-59A762D4-58AA-451A-BC1D-9D24568FD89DQ38673511-68D1B5F6-3B2A-4A9F-8BD5-81151FC698CDQ38893460-1BC7B597-4E9D-4644-90AB-F23493C0364CQ39644339-AC868D35-643B-4E7F-B61E-44D9343DB655Q40089946-A11233BC-E328-4D60-A000-E9E5DA5962A3Q40218846-5A13983D-EF92-43AB-8292-93444461081AQ41846085-6CBBFC10-216A-4BF8-A67E-A8CC1149D1EFQ41935042-B9153DD0-E334-47DC-8760-D554902034B5Q53362045-320F50AB-ED8E-42D8-A4AE-BECABE2AA1DA
P2860
Expression and activity of SRC regulate interleukin-8 expression in pancreatic adenocarcinoma cells: implications for angiogenesis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expression and activity of SRC ...... implications for angiogenesis.
@en
type
label
Expression and activity of SRC ...... implications for angiogenesis.
@en
prefLabel
Expression and activity of SRC ...... implications for angiogenesis.
@en
P2093
P1433
P1476
Expression and activity of SRC ...... implications for angiogenesis.
@en
P2093
Cheryl H Baker
Donald P Lesslie
Gary E Gallick
Jose G Trevino
Justin M Summy
Michael J Gray
Monique B Nilsson
P304
P356
10.1158/0008-5472.CAN-04-3858
P407
P577
2005-08-01T00:00:00Z